Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Watson Pharmaceuticals to Acquire Actavis?
5:00 AM MDT | March 23, 2012 | Deepti Ramesh
Watson Pharmaceuticals (Parsippany, NJ), a leading manufacturer of generic, branded and biologic pharmaceutical products, is close to acquiring Actavis (Zug, Switzerland), the world's fourth largest manufacturer of generic pharmaceuticals, for about $7 billion, say reports. Actavis also manufactures a range of active pharmaceutical ingredients (APIs) mainly for the European and U.S. markets. The deal would give Watson a larger presence in the European market. Watson recorded sales of $4.6 billion in 2011. Actavis, which moved its headquarters to Zug, from...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee